The agency noted that the failed dissolution of potassium chloride extended release capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat ...

Glenmark Pharmaceuticals Inc. issued a recall for some of its Potassium Chloride Extended-Release Capsules over a "failed dissolution" that may cause heart attacks.

A total of 135 batches of potassium chloride capsules have been recalled because the extended release capsules might not release. Glenmark Laboratories recalled 114 batches of 750 mg Potassium ...

Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

The FDA released an announcement for a voluntary national recall of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K on Tuesday, June 25th. Glenmark Pharmaceuticals Inc., USA ...

A total of 135 batches of potassium chloride capsules have been recalled because the extended release capsules might not release. Glenmark Laboratories recalled 114 batches of 750 mg Potassium ...

Discover how potassium chloride transforms blood pressure naturally. Learn benefits, risks, and food sources of this powerful mineral for better heart health.

The US Food and Drug Administration (FDA) has announced the recall of 135 batches of potassium chloride extended-release capsules due to potential risks of cardiac arrest.

The label for Glenmark Pharmaceuticals Potassium Chloride Extended Release Capsules 100-count bottles, which were recalled along with 500-count bottles.

Risk Statement: The failed dissolution of potassium chloride extended release capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that ...